AGL 7.11 Increased By ▲ 0.08 (1.14%)
ANL 10.63 Decreased By ▼ -0.12 (-1.12%)
AVN 76.99 Decreased By ▼ -0.31 (-0.4%)
BOP 5.55 Increased By ▲ 0.06 (1.09%)
CNERGY 5.26 No Change ▼ 0.00 (0%)
EFERT 88.60 Increased By ▲ 0.10 (0.11%)
EPCL 75.70 Increased By ▲ 0.80 (1.07%)
FCCL 13.93 Increased By ▲ 0.28 (2.05%)
FFL 6.65 Increased By ▲ 0.03 (0.45%)
FLYNG 7.15 Decreased By ▼ -0.04 (-0.56%)
GGGL 10.90 No Change ▼ 0.00 (0%)
GGL 16.59 Increased By ▲ 0.07 (0.42%)
GTECH 8.69 No Change ▼ 0.00 (0%)
HUMNL 6.96 Increased By ▲ 0.02 (0.29%)
KEL 2.83 Decreased By ▼ -0.03 (-1.05%)
LOTCHEM 25.58 Increased By ▲ 0.33 (1.31%)
MLCF 25.90 Increased By ▲ 0.11 (0.43%)
OGDC 79.90 Increased By ▲ 2.50 (3.23%)
PAEL 15.57 Decreased By ▼ -0.05 (-0.32%)
PIBTL 5.94 Decreased By ▼ -0.04 (-0.67%)
PRL 17.08 Decreased By ▼ -0.11 (-0.64%)
SILK 1.25 Decreased By ▼ -0.01 (-0.79%)
TELE 10.80 Increased By ▲ 0.05 (0.47%)
TPL 9.10 No Change ▼ 0.00 (0%)
TPLP 19.68 Decreased By ▼ -0.17 (-0.86%)
TREET 28.82 Increased By ▲ 0.04 (0.14%)
TRG 78.05 Increased By ▲ 1.04 (1.35%)
UNITY 19.93 Decreased By ▼ -0.01 (-0.05%)
WAVES 12.66 Increased By ▲ 0.01 (0.08%)
WTL 1.37 Decreased By ▼ -0.01 (-0.72%)
BR100 4,091 Increased By 18.9 (0.46%)
BR30 15,023 Increased By 133.1 (0.89%)
KSE100 41,284 Increased By 124.2 (0.3%)
KSE30 15,719 Increased By 58.7 (0.37%)

Moderna

Moderna begins study of COVID-19 vaccine in adolescents
World

Moderna begins study of COVID-19 vaccine in adolescents

  • The trial will enroll 3,000 healthy participants in the United States and will assess the safety and effectiveness of two doses of the company’s vaccine candidate, mRNA-1273, given 28 days apart.
  • Rival Pfizer/BioNTech have also sought EUA after their coronavirus vaccine’s two-dose regimen proved 95% effective against COVID-19 and had no major safety issues.
Published 11 Dec, 2020 03:38pm